Gallstone (GS) disease is common and arises from a combination of genetic and environmental factors. Although genetic abnormalities specifically leading to cholesterol GSs are rare, there are clinically significant gene variants associated with cholesterol GSs. In contrast, most bilirubin GSs can be attributed to genetic defects. The pathogenesis of cholesterol and bilirubin GSs differs greatly. Cholesterol GSs are notably influenced by genetic variants within the ABC protein superfamily, including ABCG8, ABCG5, ABCB4, and ABCB11, as well as genes from the apolipoprotein family such as ApoB100 and ApoE (especially the E3/E3 and E3/E4 variants), and members of the MUC family. Conversely, bilirubin GSs are associated with genetic variants in highly expressed hepatic genes, notably UGT1A1, ABCC2 (MRP2), ABCC3 (MRP3), CFTR, and MUC, alongside genetic defects linked to hemolytic anemias and conditions impacting erythropoiesis. While genetic cases constitute a small portion of GS disease, recognizing genetic predisposition is essential for proper diagnosis, treatment, and genetic counseling.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10899874 | PMC |
| http://dx.doi.org/10.14218/JCTH.2023.00563 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inclisiran as a siRNA Inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9); Past, Present, and Future.
Am J Cardiovasc Drugs
December 2024
Department of Internal Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, 1000 Oakland Dr, Kalamazoo, MI, USA.
Reducing low-density lipoprotein cholesterol (LDL-C) levels has been shown to reduce the risk of developing atherosclerotic cardiovascular disease (ASCVD). Statins are the foundation of LDL-C lowering therapy with other non-statin agents used in circumstances where goal LDL-C levels are not reached or owing to intolerance to adverse effects of statins. In 2003, the discovery of the role of the proprotein convertase subtilisin/kexin type 9 (PCSK9) system in promoting elevated LDL-C levels led to new avenues of drug development to achieve target LDL-C.
View Article and Find Full Text PDFAssessment of Sleep Quality in Adolescents with Overweight and Obesity Using the Adolescent Sleep Hygiene Scale (ASHS).
Children (Basel)
November 2024
Program of Postgraduate Studies "Adolescent Medicine and Adolescent Health Care", School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Article Synopsis
- Adolescent obesity and overweight are on the rise, and this study aims to explore the relationship between sleep quality and body weight in adolescents aged 12-18.
- The research involved 100 participants whose health metrics were assessed, including blood tests and sleep quality evaluated through the Adolescent Sleep Hygiene Scale (ASHS).
- Findings indicated that most adolescents reported good sleep quality, but poor sleepers had higher body mass indices, and factors like BMI, fasting insulin levels, and insulin resistance negatively impacted sleep quality, while certain cholesterol levels positively correlated with it.*
Methionine and vitamin E supplementation improve production performance, antioxidant potential, and liver health in aged laying hens.
Poult Sci
December 2024
Laboratory of Quality and Safety Risk Assessment for Animal Products on Feed Hazards, Ministry of Agriculture and Rural Affairs, Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing, 100081, China. Electronic address:
Sulfur metabolites of methionine (Met) and vitamin E (VE) have antioxidant potential and can maintain liver health in chickens. This study explored the underlying mechanisms of Met sources, the ratio of total sulfur amino acids to lysine (TSAA: Lys), and VE levels on production performances, antioxidant potential, and hepatic oxidation in aged laying hens. Eight hundred and sixty-four, Hy-Line Brown laying hens (70-week age) were divided into 12 treatment groups, each having 6 repeats and 12 birds/each repeat.
View Article and Find Full Text PDFModifying Membranotropic Action of Antimicrobial Peptide Gramicidin S by Star-like Polyacrylamide and Lipid Composition of Nanocontainers.
Int J Mol Sci
August 2024
Department of Life Sciences and Systems Biology, University of Turin, Via Accademia Albertina 13, 10123 Turin, Italy.
Gramicidin S (GS), one of the first discovered antimicrobial peptides, still shows strong antibiotic activity after decades of clinical use, with no evidence of resistance. The relatively high hemolytic activity and narrow therapeutic window of GS limit its use in topical applications. Encapsulation and targeted delivery may be the way to develop the internal administration of this drug.
View Article and Find Full Text PDFCholesterol Gallstones and Long-Term Use of Statins: Is Gut Microbiota Dysbiosis Bridging over Uncertainties?
Diagnostics (Basel)
June 2024
Department V of Internal Medicine I, "V Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Article Synopsis
- A study involving 300 participants, including dyslipidemic patients on and off statins and healthy controls, aimed to explore the connection between long-term statin use, gallstone disease (GSD), and gut microbiota differences.
- Results showed that gut dysbiosis was more prevalent in statin-negative patients, and GSD was less common in those on statins, suggesting a protective effect.
- Significant correlations were found between GSD and conditions like obesity and diabetes, with gut dysbiosis and obesity identified as independent risk factors for GSD among statin patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!